私たちの拠点

ベルギー事務所(HBRI本部)は1983年に設立された。ベルギーでは、セルバ・ヘルスケア・グループに属する通常の医療ラボであるCRIが組み込まれています。 

Formerly known as HISかつて彼の才能として知られていたモンペリエは、私たちの専門組織体理学研究所です。ヒストパロジーと免疫組織化学に重点を置いたこの実験室では、クライアントが1つのスライドで最大8つのマーカーを測定することで、バイオマーカー情報を解きほぐすことができる。 

Paris is in vitroパリは当社の主要な体外診断ラボであり、体外受精装置の評価、品質管理ソリューションの開発、およびIVD製品の販売を支援する、完全かつカスタマイズされたソリューションを提供します。 

Leading diagnostic and clinical trial operation services supporting clinical and preclinical drug and vaccine development studies to prevent and treat viral infections.

Rijswijk is a state-of-the-art laboratory specialized in (molecular) diagnostic testing and diagnostic assay development. The lab performs advanced (molecular) diagnostic testing on behalf of pharmaceutical companies and clinical laboratories, within the complex framework of preclinical studies and phase I-IV clinical trials.

Schaijk offers preclinical services including testing of efficacy, safety, PK and (immune) toxicology of drugs, antibodies, vaccines and antivirals targeting viral infectious diseases. The BSL-2 and BSL-3 facilities enable complicated experiments with highly pathogenic viruses. The qualified biotech staff and use of state of the art BSL2 and BSL3 in vivo facilities are key to a successful outcome of studies.

Pursuing a true global reach, HBRI opened an office in New York in 2001, establishing a partnership with Northwell Health.

HBRI Canada (formerly CIRION BioPharma Research) is a Canadian based company, highly recognized for its integrated large molecules, biologics and biosimilars bioanalytical and global central laboratory services. CIRION is a large GLP certified facility (35,000 sq/f and 3,250 sq/m), CAP and CLIA accredited, with a global central laboratory footprint.

Strong presence in South Africa supports customers with laboratory testing and operations for a wide range of therapeutic areas, including HIV, TB, HPV, HBV, Oncology, and Diabetes.

Strong presence in South Africa supports customers with laboratory testing and operations for wide range of therapeutic areas including HIV, TB, HPV, HBV, Oncology, Diabetes.

Strong presence in South Africa supports customers with laboratory testing and operations for wide range of therapeutic areas including HIV, TB, HPV, HBV, Oncology, Diabetes.

Our Sydney branch opened in 1997. Here, HBRI operates in collaboration with SDS Pathology (Laverty Pathology Lab), the largest routine medical laboratory in Australia.

Through CerbACT, our immuno-oncology Center of Excellence, we empower precision medicine research by applying deep and wide biomarker expertise, translational research, and clinical development strategy.

In 2012, HBRI established a partnership with DIAN Diagnostics, which has the largest network of laboratories across China. In 2018 we deepened our China footprint by partnering with Teddy Lab, a central lab in Shanghai. Teddy Lab is the result of a merger between DIAN and Tigermed.

HBRI works in partnership with SRL Medisearch to assist your clinical trials within Japan.